Detalhe da pesquisa
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153814
2.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
3.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363892
4.
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment.
Haematologica
; 107(6): 1410-1426, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670358
5.
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.
Cancer
; 127(12): 2015-2024, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739457
6.
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.
Haematologica
; 106(10): 2598-2612, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855274
7.
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Eur J Haematol
; 107(5): 573-582, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297437
8.
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs.
Haematologica
; 105(10): 2420-2431, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054082
9.
Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department.
Hematol Oncol
; 37(3): 285-290, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485475
10.
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
J Transl Med
; 16(1): 295, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359253
11.
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Haematologica
; 103(1): 80-90, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025907
12.
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(7): 1242-1246, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970379
13.
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.
Eur J Nucl Med Mol Imaging
; 43(2): 232-239, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26283504
14.
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients.
Am J Hematol
; 91(8): 755-62, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084986
15.
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach.
Br J Haematol
; 186(6): e223-e225, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348524
16.
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information.
Br J Haematol
; 184(3): 457-460, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359798
17.
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration.
Radiology
; 271(3): 805-13, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24592961
18.
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
Ann Hematol
; 93(12): 2011-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24989345
19.
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.
Biol Blood Marrow Transplant
; 19(1): 117-22, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22940057
20.
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Hematol Oncol
; 36(2): 498-499, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052244